top of page

Datametrex PLANS TO FOCUS ON AI, DATA CENTRE, AND PATENT LICENSING

  • 6 hours ago
  • 3 min read

Toronto, Canada, September 2, 2026 – Datametrex AI Limited (the "Company" or

"Datametrex") (TSXV: DM) (FSE: D4G) (OTC: DTMXF is pleased to announce that it

has initiated plans to wind down its health care operations.

 

The wind-down is intended to allow the Company to focus its resources and

management efforts on its core AI, data centre technology, and patent licensing

businesses, optimize its current operations and resources, reduce operating and

regulatory compliance requirements, and improve overall financial performance.

 

As part of the wind-down process, the Company intends to gradually reduce and

ultimately cease its health care operations, including the operation of its multi-

disciplinary medical clinics in Edmonton and Calgary, Alberta, and Vancouver, British

Columbia. These clinics currently provide a range of health care and related services,

including primary and emergency care.

 

The Company will take a measured and orderly approach to the wind-down process,

with the timing and scope of the reduction of operations determined based on

operational, financial, contractual and regulatory considerations. The Company intends

to manage the transition in an orderly manner and will continue to assess opportunities

to maximize value from its health care assets and operations during the wind-down

process.

 

The Company expects the wind-down of its health care operations to allow Quanta AI to

simplify its corporate structure and focus on its AI,data centre technology, and patent

licensing businesses. The Company believes that this strategic focus will allow

management to allocate capital and resources toward its core business areas and

pursue opportunities that are aligned with the Company’s long-term objectives. In this

regard, its patent licensing initiatives remain active. The Company will be making further

announcements, as events warrant.

 

About Datametrex

 

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and

Healthcare. The Company specializes in delivering tools and solutions that enhance

operational efficiencies and business outcomes. With a commitment to innovation,

Datametrex is dedicated to supporting enterprises by setting a new standard for

business protocols through cutting-edge technology.

 

For more on Datametrex, please visit our Company website (www.datametrex.com).

 

For Additional Information

 

Michael Kron

CEO & Chairman

416-901-5611

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is

defined in the policies of the TSX Venture Exchange) accepts responsibility for the

adequacy or accuracy of this release.

 

Forward-Looking Statements

 

This news release contains "forward-looking statements," which involve risks,

uncertainties, and factors that could cause actual results to differ materially from those

anticipated. These statements are not historical facts and are generally identified by

words such as "expects," "plans," "anticipates," "believes," "intends," "estimates,"

"projects," and similar expressions. Such statements include expectations related to the

Company plans and performance.

 

Forward-looking statements are neither historical facts nor assurances of future

performance. Instead, they are based only on our current beliefs, expectations and

assumptions regarding the future of our business, future plans and strategies,

projections, anticipated events and trends, the economy and other future conditions.

Because forward-looking statements relate to the future, they are subject to inherent

uncertainties, risks and changes in circumstances that are difficult to predict and many

of which are outside of our control. Our actual results and financial condition may differ

materially from those indicated in the forward-looking statements. Therefore, you should

not rely on any of these forward-looking statements.

 

While Datametrex believes the forward-looking information is reasonable as of the date

of this release, these statements involve assumptions, risks, and uncertainties that

could cause actual outcomes to differ. Key factors include general economic conditions,

legislative and regulatory developments, access to capital, industry competition, and the

Company's ability to execute its strategies. Except as required by applicable securities

laws, we undertake no obligation to publicly update any forward-looking statement,

whether written or oral, that may be made from time to time, whether as a result of new

information, future developments or otherwise.

 

Readers are advised not to place undue reliance on forward-looking information.

 

Factors that could cause actual results to differ materially are detailed under "Risk

Factors" in Datametrex's management's discussion and analysis and available on the

Company’s profile at www.sedarplus.ca.

 

This release does not constitute an offer to sell or a solicitation to buy, nor shall it

constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful

prior to registration or qualification under applicable securities laws. We seek Safe

Harbor.

Recent Posts

See All
bottom of page